![Logo for Inhibikase Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F7ec27-2023-04-03-08-37-32.png&w=256&q=100)
Inhibikase Therapeutics Investor Relations Material
Latest events
![Logo for Inhibikase Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F7ec27-2023-04-03-08-37-32.png&w=128&q=100)
Q1 2024
Inhibikase Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Inhibikase Therapeutics Inc
Access all reports
Inhibikase Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of therapeutics for neurological disorders associated with genetic mutations and protein-protein interactions. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain; IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers; and Ibuprofen Knee Pain, Pain Relief Capsules. It also has programs underway for other neurological diseases such as Duchenne Muscular Dystrophy (DMD), Friedreich Ataxia, and Alzheimer's disease.
Key slides for Inhibikase Therapeutics Inc
![Ікт
Multi - Indicat](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Finhibikase-therapeutics-inc-investor-presentation-fd95021a00656fd5%2F4.png&w=3840&q=75)
![Logo for Inhibikase Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F7ec27-2023-04-03-08-37-32.png&w=128&q=100)
Investor Presentation
Inhibikase Therapeutics Inc
![SEARCHING FOR THE RO](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Finhibikase-therapeutics-inc-investor-presentation-fd95021a00656fd5%2F7.png&w=3840&q=75)
![Logo for Inhibikase Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F7ec27-2023-04-03-08-37-32.png&w=128&q=100)
Investor Presentation
Inhibikase Therapeutics Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
IKT
Country
🇺🇸 United States